Dindin, Cerilo C.
HRN: 25-63-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2026
TENOFOVIR DISOPROXIL FUMARATE 300MG TAB
01/15/2026
01/21/2026
PO
300 Mg
OD
Intraabdominal Infection , Liver Cirrhosis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes